Oesophageal Cancer: Symptoms, Causes, and Early Warning Signs

Oesophageal cancer, commonly known as food pipe cancer, often develops without clear warning. In its early stages, symptoms such as mild difficulty swallowing, persistent indigestion, or a vague tightness in the chest are easy to attribute to something less serious — and most people do exactly that.

This is what makes early recognition so important. By the time oesophageal cancer produces obvious symptoms, the disease has frequently progressed to a stage where treatment is more complex. Paying attention to changes that persist, such as difficulty swallowing, unexplained weight loss, or ongoing chest discomfort, and seeking evaluation promptly can make a significant difference to outcomes.

At RGCIRC, our multidisciplinary team brings together GI surgical oncologists, medical oncologists, radiation oncologists, and gastroenterologists to ensure every patient receives an accurate diagnosis and a personalised, evidence-based treatment plan from the outset.

What is Oesophageal Cancer?

The oesophagus is a hollow, muscular tube, approximately 25 centimetres long, that carries food and liquids from the throat to the stomach. Its inner lining is made up of specialised epithelial cells that are constantly exposed to friction, temperature variations, and the chemical effects of what we eat and drink.

Oesophageal cancer develops when these cells undergo genetic changes that cause them to grow and divide uncontrollably, forming a tumour. As the tumour enlarges, it gradually narrows the passage of the oesophagus. This is why difficulty swallowing is the most common and defining symptom. In more advanced stages, the cancer may spread through the oesophageal wall to nearby structures or travel to distant organs through the lymphatic system or bloodstream.

One of the key challenges with oesophageal cancer is that it often does not cause noticeable symptoms in its early stages. As a result, many cases are diagnosed later, when treatment becomes more complex. This makes awareness of risk factors and timely evaluation of persistent symptoms especially important for earlier detection and better outcomes.

Types of Oesophageal Cancer

Oesophageal cancer is broadly classified into two main types based on the cells from which it originates. These types differ in their location within the oesophagus, underlying risk factors, and patterns of occurrence across populations. Understanding this distinction is clinically important, as it helps guide both risk assessment and treatment planning. The types include:

Squamous Cell Carcinoma

Squamous cell carcinoma (SCC) develops from the flat, scale-like cells lining most of the oesophagus. It commonly occurs in the upper and middle sections of the oesophagus and remains the most prevalent type globally, particularly in India. Higher incidence is seen in regions such as north-eastern states and Jammu and Kashmir.

Key risk factors include:

• Tobacco use
• Alcohol consumption
• Diets low in fruits and vegetables
• Regular intake of very hot beverages, which can cause repeated thermal injury to the oesophageal lining

Adenocarcinoma

Adenocarcinoma arises from glandular cells, typically in the lower part of the oesophagus near its junction with the stomach. While it is more common in Western countries, its incidence has been increasing globally. In India, it is less common than SCC but is being seen more frequently, especially in urban populations.

Key risk factors include:

• Chronic acid reflux (GERD)
• Barrett’s oesophagus
• Obesity or high body mass index
• Smoking

Recognising the type of oesophageal cancer helps guide both prevention strategies and the choice of treatment, making early evaluation of symptoms and risk factors particularly important.

Signs and Symptoms of Oesophageal Cancer

Early oesophageal cancer often does not cause clear symptoms. As the disease progresses, signs begin to appear due to narrowing of the oesophagus or involvement of nearby structures. The following warning signs should not be ignored and require medical evaluation, especially if they persist.

Dysphagia (Difficulty Swallowing)

This is the most common and defining symptom. It usually begins with difficulty swallowing solid foods and gradually progresses to soft foods and liquids as the tumour grows. Any new or worsening swallowing difficulty lasting more than two weeks should be evaluated.

Unexplained Weight Loss

Unintentional weight loss is common and may occur due to reduced food intake, cancer-related metabolic changes, or nutritional imbalance. Losing more than 5–10% of body weight over a short period without trying is a key warning sign.

Persistent Heartburn or Chest Discomfort

Some people experience burning pain behind the chest, regurgitation, or ongoing indigestion. While these symptoms are often linked to common conditions, heartburn that is new, worsening, or not responding to treatment, especially after the age of 50, needs further assessment.

Persistent Cough or Hoarseness

A long-standing cough or change in voice may occur if the tumour affects nearby structures such as the airway or nerves controlling the voice. These symptoms are more common in advanced stages but should not be overlooked.

Vomiting or Coughing Up Blood

The presence of blood in vomit (haematemesis) or while coughing (haemoptysis) can indicate tumour-related damage to the lining or nearby blood vessels. This requires immediate medical attention.

Symptoms of Advanced Disease

In later stages, additional signs may develop due to spread of the cancer. These can include:

• Swelling of lymph nodes in the neck or above the collarbone
• Jaundice or abdominal swelling if the liver is involved
• Bone pain if the cancer has spread to the bones
• Ongoing fatigue and general weakness

A Note on Symptoms in Women

Women may sometimes attribute early symptoms such as heartburn or mild swallowing difficulty to stress, hormonal changes, or menopause. This can delay diagnosis. Persistent symptoms, especially difficulty swallowing or unexplained weight loss, should always be evaluated by a specialist rather than being dismissed.

Causes, Risk Factors, and Associated Conditions

There is no single cause of oesophageal cancer. Current clinical understanding suggests that it develops over time due to repeated irritation and inflammation of the oesophageal lining, leading to cellular changes that may become cancerous. The following factors are known to increase this risk.

Chronic Acid Reflux and GERD

Long-standing gastroesophageal reflux disease (GERD) is a major risk factor for oesophageal adenocarcinoma. Repeated exposure to stomach acid damages the lining of the oesophagus, causing chronic inflammation. Over time, this may lead to Barrett’s oesophagus, a precancerous condition seen in about 10 to 15% of people with chronic reflux.

Barrett’s Oesophagus

This condition involves a change in the lining of the lower oesophagus, where normal cells are replaced by intestinal-type cells due to prolonged acid exposure. It is the most important precursor to adenocarcinoma. The risk of cancer increases significantly if abnormal (dysplastic) cells are present, making regular endoscopic monitoring essential.

Tobacco Use

Both smoking and smokeless tobacco increase the risk of oesophageal cancer. Harmful chemicals in tobacco directly damage the DNA of oesophageal cells. When combined with alcohol use, the risk, particularly for squamous cell carcinoma, increases substantially.

Alcohol Consumption

Regular alcohol intake is a well-established risk factor, especially for squamous cell carcinoma. Alcohol irritates the oesophageal lining and produces acetaldehyde during metabolism, a substance known to promote cancer development.

Obesity

Excess body weight, particularly around the abdomen, raises the risk of adenocarcinoma. It contributes to acid reflux and creates a pro-inflammatory environment in the body, both of which can promote cancer development.

Frequent Consumption of Very Hot Beverages

Regular intake of very hot drinks, such as tea or coffee at high temperatures, can repeatedly damage the oesophageal lining. This chronic thermal injury has been linked to an increased risk of squamous cell carcinoma, especially in certain Indian populations.

Achalasia

Achalasia is a condition in which the oesophagus has difficulty moving food into the stomach due to improper relaxation of the lower sphincter. Food stagnation leads to prolonged irritation of the lining, increasing the risk of cancer over time.

Human Papillomavirus (HPV)

Some studies suggest a possible link between HPV infection and squamous cell carcinoma of the oesophagus, particularly in high-incidence regions. However, this association is still being studied and is not as clearly established as in other cancers.

Prior Head and Neck Cancer

People with a history of cancers in the head and neck region have a higher risk of developing oesophageal cancer. This is largely due to shared risk factors such as tobacco and alcohol use, as well as long-term exposure of the upper digestive tract to carcinogens.

Age and Sex

Oesophageal cancer is more commonly diagnosed in men and typically occurs after the age of 50. While these factors cannot be changed, they help identify individuals who may benefit from closer monitoring, especially when combined with other risk factors.

Stages of Oesophageal Cancer

Staging helps determine how far the cancer has spread and plays a central role in deciding the most appropriate treatment approach. The TNM system (Tumour, Node, Metastasis) is used to assess tumour depth, lymph node involvement, and whether the cancer has spread to distant organs.

The stage at diagnosis is the most important factor in determining treatment and expected outcomes. Early-stage cancers (Stage I and selected Stage II) may be treated with curative intent. Stage III disease often requires a combination of surgery, chemotherapy, and radiation therapy. Stage IV disease is usually managed with systemic treatments focused on disease control and maintaining quality of life.

How is Oesophageal Cancer Diagnosed?

Accurate diagnosis and staging of oesophageal cancer require a combination of clinical assessment, imaging, and tissue analysis. The diagnostic pathway at RGCIRC follows a stepwise approach, where each investigation builds on the findings of the previous one to ensure precise evaluation and treatment planning.

Upper Gastrointestinal Endoscopy

This is the primary and most definitive test. A flexible camera is passed through the mouth to examine the oesophagus and stomach, allowing doctors to directly identify abnormalities, tumours, or Barrett’s changes. If needed, biopsy samples are taken during the same procedure.

Biopsy

Tissue samples collected during endoscopy are analysed under a microscope to confirm the presence of cancer. This also helps determine the type of cancer (squamous cell carcinoma or adenocarcinoma), its grade, and, in some cases, molecular features that may guide targeted therapy.

Barium Swallow

In this test, the patient drinks a contrast solution while X-ray images are taken. It helps assess the location, length, and degree of narrowing in the oesophagus. It is useful when endoscopy is not possible or as an additional diagnostic tool. It is done in selected cases when perforation of leak is suspected, water-soluble contrast is used rather than Barium.

CT Scan (Chest, Abdomen, and Pelvis)

CT imaging provides a detailed view of the tumour’s extent, involvement of nearby structures, lymph node status, and spread to organs such as the liver or lungs. It is a key component of staging.

PET-CT Scan

A PET-CT scan is used in selected cases to detect distant metastasis and evaluate response to treatment. It is particularly helpful when CT findings are unclear. Advanced Digital PET-CT facilities are available at both campuses of RGCIRC.

Endoscopic Ultrasound (EUS)

EUS offers highly detailed imaging of how deeply the tumour has invaded the oesophageal wall and whether nearby lymph nodes are involved. It is the most accurate method for local staging and plays a critical role in deciding the treatment approach.

How is Oesophageal Cancer Treated?

Treatment for oesophageal cancer depends on several factors, including the stage of the disease, tumour type, location, and the patient’s overall health and nutritional status. At RGCIRC, every case is reviewed by the Multidisciplinary Tumour Board to create an individualised, evidence-based treatment plan. Treatment approach include:

Surgery

Surgery is the main curative option for early and localised disease in suitable patients. The approach is carefully selected based on tumour extent and patient fitness.

• Oesophagectomy: Removal of part or all of the oesophagus along with nearby lymph nodes. The digestive tract is reconstructed using the stomach or a segment of the intestine
• Multivisceral resection: Performed when the tumour involves nearby organs, requiring removal of multiple structures to achieve complete clearance
• Endoscopic resection (EMR/ESD): Minimally invasive techniques used for very early-stage cancers confined to the inner layers of the oesophagus
• Endoscopic laser therapy and photodynamic therapy (PDT): Used in selected cases for symptom relief, treatment of early lesions, or management of Barrett’s oesophagus with high-grade changes

Chemotherapy

Chemotherapy plays a role at different stages of treatment:

• Neoadjuvant therapy: Given before surgery to shrink the tumour and improve surgical outcomes
• Adjuvant therapy: Given after surgery to reduce the risk of recurrence
• Advanced disease: Used as the primary treatment to control disease and relieve symptoms

Radiation Therapy

Radiation is often combined with chemotherapy (concurrent chemoradiation), especially in locally advanced disease. It may be used as a primary treatment in patients who are not candidates for surgery or before surgery to improve outcomes. Advanced techniques such as IMRT and IGRT allow precise targeting while protecting nearby organs.

Targeted Therapy

Some oesophageal cancers have specific molecular markers that can be targeted with specialised drugs. For example:

• HER2-positive cancers: May be treated with trastuzumab
• VEGFR2-targeted therapy: Used in certain advanced cases
  Molecular testing helps identify patients who may benefit from these therapies.

Immunotherapy

Immunotherapy has become an important option in advanced oesophageal cancer. Drugs such as nivolumab and pembrolizumab help the immune system recognise and attack cancer cells. Their use is guided by specific markers, including PD-L1 expression, and is decided through multidisciplinary evaluation.

A combination of these treatments is often used to achieve the best possible outcome, with a strong focus on both disease control and quality of life.

Diet, Lifestyle, and Prevention

Oesophageal cancer is influenced by several modifiable risk factors. This means that making informed dietary and lifestyle choices can help reduce risk and, for those undergoing treatment, support recovery and quality of life.

Dietary Recommendations

Making the right food choices can help protect the oesophageal lining and reduce inflammation. The following guidelines are recommended:

Foods to include

• Fresh fruits and vegetables rich in antioxidants and dietary fibre
• Whole grains that support digestion
• Lean proteins such as fish, pulses, and eggs
• Probiotic-rich foods that promote gut health

Foods and habits to avoid

• Alcohol in any form
• Tobacco use (smoked or smokeless)
• Very hot beverages; allow drinks to cool before consuming
• Highly processed, preserved, or pickled foods
• Red and processed meats
• Foods that worsen acid reflux, such as fried or fatty meals, excess citrus, chocolate, and carbonated drinks

For patients experiencing difficulty swallowing, dietary adjustments are essential. Soft or pureed foods, smaller frequent meals, and adequate hydration help maintain nutrition. At RGCIRC, dietary planning with a clinical dietician is an important part of patient care.

Lifestyle Modifications

Certain lifestyle changes can significantly lower the risk of oesophageal cancer, especially for individuals with existing risk factors.

• Quit tobacco: The most effective preventive step, reducing long-term exposure to cancer-causing substances
• Limit alcohol intake: Lowering or eliminating alcohol reduces the risk, particularly when combined with tobacco cessation
• Maintain a healthy weight: Helps reduce acid reflux and chronic inflammation linked to cancer development
• Manage GERD effectively: Early treatment of acid reflux through medication and lifestyle changes can prevent complications
• Regular monitoring for Barrett’s oesophagus: Patients with this condition should follow recommended endoscopic surveillance schedules

Prevention Through Early Screening

There is no routine population-wide screening programme for oesophageal cancer in India. However, early evaluation is strongly advised for high-risk individuals, including those with long-standing GERD, Barrett’s oesophagus, combined tobacco and alcohol use, or a history of head and neck cancer.

Timely endoscopic screening in such cases improves the chances of detecting oesophageal cancer at an early stage, when treatment outcomes are significantly better.

When to See a Specialist at RGCIRC

Oesophageal cancer is most treatable when identified early, yet many patients seek care only after symptoms become significant. Recognising early warning signs and acting on them without delay can make a meaningful difference in outcomes. Seek a specialist evaluation promptly if you experience any of the following:

• Progressive difficulty swallowing, even if mild or intermittent
• Unintentional weight loss of more than 5% over one to two months
• Persistent heartburn or regurgitation that is new, worsening, or not responding to medication
• A known history of Barrett’s oesophagus or long-standing GERD without recent evaluation
• Vomiting or coughing up blood
• Ongoing hoarseness or a chronic cough without a clear respiratory cause
• Family history of oesophageal or gastric cancer along with digestive symptoms

Why Choose RGCIRC for Oesophageal Cancer Care

RGCIRC has been delivering specialist cancer care since 1996 and is today counted among Asia’s premier exclusive cancer centres. For patients with oesophageal cancer, that institutional depth translates into something clinically meaningful: a team that has seen this disease across every stage, every subtype, and every treatment complexity.

A Multidisciplinary Team That Reviews Every Case Together
Advanced Technology Under One Roof
Accredited, Recognised, and Trusted
Care That Goes Beyond Treatment

As a not-for-profit institution, RGCIRC’s Philanthropy Department extends financial aid and subsidised treatments to patients who need support, ensuring that quality cancer care is not determined by what a patient can afford.

Book a Consultation at RGCIRC

If you are experiencing symptoms that concern you, or carry risk factors such as long-standing acid reflux, Barrett’s oesophagus, or a history of tobacco use, do not wait for symptoms to worsen. An early consultation with our GI Oncosurgery team is the most effective step you can take. To book a consultation, call +91-11-4702 2222 (Rohini) / +91-11-4582 2222 (Niti Bagh, South Delhi) Book online at care.rgcirc.org | Download the RGCI Care app on iOS and Android

OPD Hours: Monday to Saturday, 9:00 AM to 5:00 PM | Emergency Services: 24×7 at both campuses

Frequently Asked Questions (FAQs)

What are the first signs of oesophageal cancer?

The earliest sign is usually progressive difficulty swallowing, starting with solids and later affecting liquids. Other warning signs include persistent heartburn, unexplained weight loss, and a sensation of food getting stuck. In many cases, early-stage disease has no symptoms, which is why high-risk individuals benefit from regular screening.

Can oesophageal cancer be cured if detected early?

Yes. Early-stage cancers (Stage I and selected Stage II) can often be treated with curative intent using surgery, endoscopic procedures, or chemoradiation. Outcomes are significantly better when the disease is diagnosed early.

Can GERD (acid reflux) lead to oesophageal cancer?

Yes. Chronic GERD can lead to Barrett’s oesophagus, a precancerous condition that increases the risk of adenocarcinoma. The risk rises with long-standing reflux, especially when combined with obesity or tobacco use.

What is Barrett’s oesophagus, and why is it important?

Barrett’s oesophagus is a condition where the normal lining of the oesophagus changes due to prolonged acid exposure. It significantly increases the risk of oesophageal cancer, making regular endoscopic monitoring essential.

Who is at the highest risk of developing oesophageal cancer?

Higher risk is seen in older adults, especially men, with long-standing GERD, Barrett’s oesophagus, obesity, tobacco use, or heavy alcohol intake. In India, individuals from high-incidence regions and those with a history of head and neck cancer are also at increased risk.

What are the stages of oesophageal cancer?

Oesophageal cancer ranges from Stage 0 (confined to the lining) to Stage IV (spread to distant organs). The stage at diagnosis determines treatment options and prognosis.

Is oesophageal cancer hereditary?

Most cases are not hereditary. They are primarily linked to lifestyle and environmental factors. However, a family history may slightly increase risk, especially when combined with other factors.

What foods should be avoided with oesophageal cancer?

Avoid alcohol, tobacco, very hot beverages, processed and pickled foods, fried and fatty meals, and carbonated drinks. Red and processed meats may also increase risk. Dietary guidance from a specialist is recommended.

What is the survival rate of oesophageal cancer?

Overall five-year survival is around 18–20%, but this improves significantly with early detection. Early-stage disease has much better outcomes compared to advanced stages.

What is the difference between oesophageal cancer and gastroesophageal junction cancer?

Gastroesophageal junction (GEJ) cancer occurs where the oesophagus meets the stomach. It shares risk factors with adenocarcinoma but may differ in surgical approach and treatment planning.